Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease?

Eur Heart J. 2017 May 21;38(20):1542-1547. doi: 10.1093/eurheartj/ehw287.

Maarten J G Leening^{1

2

3

4}, Nancy R Cook^{1

2}, Paul M Ridker^{1

2}

¹ Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine and Cardiology, Brigham and Women's Hospital, Boston, MA, USA.
² Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
³ Department of Cardiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁴ Department of Epidemiology, Erasmus MC - University Medical Center Rotterdam, PO Box 2040, Rotterdam 3000 CA, The Netherlands.

No abstract available

Publication types